| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/29/1999 | WO1999020755A2 Novel cytokine receptors |
| 04/29/1999 | WO1999020739A2 Novel lactic acid bacteria species |
| 04/29/1999 | WO1999020653A1 Low-toxicity human interferon-alpha analog |
| 04/29/1999 | WO1999020647A1 Hysteromyoma remedy containing dienogest as the active ingredient |
| 04/29/1999 | WO1999020646A1 Estra-1,3,5(10)-triene-7alpha-thioethers |
| 04/29/1999 | WO1999020643A1 Using polyamide nucleic acid oligomers to engender a biological response |
| 04/29/1999 | WO1999020641A1 New triplex forming oligonucleotides and their use in anti-hbv |
| 04/29/1999 | WO1999020639A2 NOVEL 3,6-HEMIKETALS FROM THE CLASS OF 9a-AZALIDES |
| 04/29/1999 | WO1999020634A1 Novel methylenebisphosphonic acid derivatives |
| 04/29/1999 | WO1999020633A1 Benzoxazine derivatives, preparation and application in therapy |
| 04/29/1999 | WO1999020631A1 Process for producing 3-cephem compounds |
| 04/29/1999 | WO1999020628A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 04/29/1999 | WO1999020627A1 Carbapenem antibacterial compounds, compositions and methods of treatment |
| 04/29/1999 | WO1999020625A1 Novel polymorphic forms of cipamfylline |
| 04/29/1999 | WO1999020624A1 Bicyclic kinase inhibitors |
| 04/29/1999 | WO1999020622A1 3-oxo-2(h)-1,2,4-triazine derivatives as ligands of 5ht1a receptors |
| 04/29/1999 | WO1999020621A1 ARYLPIPERAZINES AS SEROTONIN REUPTAKE INHIBITORS AND 5-HT1Dα ANTAGONISTS |
| 04/29/1999 | WO1999020616A1 2-substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-ht1a, 5-ht1b and 5-ht1d) |
| 04/29/1999 | WO1999020614A1 Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/29/1999 | WO1999020613A1 Cyclohexane derivatives difunctionalised in 1,4 as ligands of 5t h1a receptors |
| 04/29/1999 | WO1999020612A1 Imidazole derivatives and their use as farnesyl protein transferase inhibitors |
| 04/29/1999 | WO1999020611A1 Imidazole derivatives and their use as farnesyl protein transferase inhibitors |
| 04/29/1999 | WO1999020608A1 Isoquinolines as urokinase inhibitors |
| 04/29/1999 | WO1999020607A1 Amide derivatives or salts thereof |
| 04/29/1999 | WO1999020601A1 α-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| 04/29/1999 | WO1999020599A1 Pharmaceutically active compounds and methods of use |
| 04/29/1999 | WO1999020589A1 Medicinal uses of phenylalkanols and derivatives |
| 04/29/1999 | WO1999020310A1 J-chain and analogues as epithelial cell targeting conjugates |
| 04/29/1999 | WO1999020309A1 Retinoic acid agonists as preventive and therapeutic agents for nephritis |
| 04/29/1999 | WO1999020298A1 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 04/29/1999 | WO1999020297A1 Prevention and treatment of adhesion formation |
| 04/29/1999 | WO1999020296A1 Oral cyclosporin formulations |
| 04/29/1999 | WO1999020294A1 Activating c1- secretion |
| 04/29/1999 | WO1999020292A1 Pharmaceutical grade ginseng |
| 04/29/1999 | WO1999020285A1 Gel preparations containing polystyrenesulfonate |
| 04/29/1999 | WO1999020283A1 Intra-cancer-cell nuclease activator |
| 04/29/1999 | WO1999020282A1 Progestin therapy with controlled bleeding |
| 04/29/1999 | WO1999020281A1 Novel benzodiazepine derivatives as antiarrhythmic agents |
| 04/29/1999 | WO1999020280A1 Novel use of compounds for anti-pruritic activity |
| 04/29/1999 | WO1999020279A1 Potentiation of pharmaceuticals |
| 04/29/1999 | WO1999020278A1 Use of moxonidine for the treatment of depression |
| 04/29/1999 | WO1999020277A1 Rapidly soluble drug composition |
| 04/29/1999 | WO1999020276A1 Stable drug composition |
| 04/29/1999 | WO1999020275A1 Therapeutic uses of quinoline derivatives |
| 04/29/1999 | WO1999020273A1 Use of an inhibitor of the dephosphorylation of darpp-32 for treating schizophrenia |
| 04/29/1999 | WO1999020271A1 Use of azole derivatives for the treatment of inflammatory skin conditions |
| 04/29/1999 | WO1999020270A1 Carbapenem antibacterial compounds, compositions and methods of treatment |
| 04/29/1999 | WO1999020269A1 Antibacterial carbapenems, compositions and methods of treatmemt |
| 04/29/1999 | WO1999020268A1 (3r,4r)-δ-tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents and analgesics |
| 04/29/1999 | WO1999020266A1 Methods, compositions, and kits for enhancing female sexual desire and responsiveness |
| 04/29/1999 | WO1999020265A1 Compositions containing histamine h2 agonists and methods of use in treating dry eye |
| 04/29/1999 | WO1999020264A1 Formulations and methods for reducing toxicity of antineoplastic agents |
| 04/29/1999 | WO1999020263A1 Thyroxine analogues having no significant hormonal activity to treat malignant tumors |
| 04/29/1999 | WO1999020262A1 Remedy for meniere disease |
| 04/29/1999 | WO1999020261A2 Use of antigunal agents for the topial treatment of fungus-induced mucositis |
| 04/29/1999 | WO1999020260A2 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function |
| 04/29/1999 | WO1999020259A2 Compositions containing thiamphenicol and diclofenac |
| 04/29/1999 | WO1999020255A1 Oral morphine multiparticulate formulation |
| 04/29/1999 | WO1999020253A1 Encapsulation method |
| 04/29/1999 | WO1999020251A1 Use of inhaled no as anti-inflammatory agent |
| 04/29/1999 | WO1999020250A1 Topical antifungal composition |
| 04/29/1999 | WO1999020249A1 Solution for peritoneal dialysis and process for its manufacture |
| 04/29/1999 | WO1999020248A1 Delivery system for allergy medication via the nasal vestibules |
| 04/29/1999 | WO1999020247A1 Gel preparation containing polystyrene-sulfonates |
| 04/29/1999 | WO1999020242A1 Compositions based on plant extracts |
| 04/29/1999 | WO1999020232A1 Cosmetic formulations for the prevention and therapy of hair loss |
| 04/29/1999 | WO1999020223A2 Luteinising hormone antagonists useful for treatment of estrogen deficiencies, or as a contraceptive |
| 04/29/1999 | WO1999020123A1 Method for increasing the concentration of conjugated linoleic acid in milk and/or tissue fat of a ruminant |
| 04/29/1999 | WO1999020110A1 Combination therapy for reducing the risks associated with cardio- and cerebrovascular disease |
| 04/29/1999 | WO1999020098A1 Methods for preventing and treating bacterial infections using cellulose acetate phthalate or hydroxypropyl methylcellulose phthalate excipients |
| 04/29/1999 | WO1999007354A3 Compositions, apparatus and methods for facilitating surgical procedures |
| 04/29/1999 | WO1999006052A9 Methods of pretreating hyperlipidemic individuals with a flush inhibiting agent prior to the start of single daily dose nicotinic acid therapy to reduce flushing provoked by nicotinic acid |
| 04/29/1999 | WO1999006046A9 Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia |
| 04/29/1999 | WO1999006040A9 Method of treating disease using a tocotrienol and alpha-lipoic acid or derivatives or an ester thereof |
| 04/29/1999 | WO1999006033A3 An aqueous enteroclysis solution for the treatment of hepatic encephalopathy |
| 04/29/1999 | WO1999006026A9 Stable particulate complexes with neutral or negative global charge of lamellar structure |
| 04/29/1999 | WO1999004775A9 Method of treating dopaminergic and gaba-nergic disorders |
| 04/29/1999 | WO1999003822A9 Bicyclic metabotropic glutamate receptor ligands |
| 04/29/1999 | WO1998057931A3 Quinoline-indole antimicrobial agents, uses and compositions related thereto |
| 04/29/1999 | WO1998048027A9 Materials and methods for treatment of retinal diseases |
| 04/29/1999 | WO1998044134A3 Bacterial plasmids |
| 04/29/1999 | WO1998007715A9 Novel benzofuran-4-carboxamides |
| 04/29/1999 | DE19756864C1 Production of neuronal or glial progenitor cells |
| 04/29/1999 | DE19747261A1 Single-chamber osmotic pharmaceutical release system |
| 04/29/1999 | DE19747195A1 Compositions for treating diabetic retinopathy |
| 04/29/1999 | DE19747063A1 New 3-substituted tetrahydropyridopyrimidinone derivatives |
| 04/29/1999 | DE19746612A1 New 2-substituted 1,2-benzisothiazole derivatives |
| 04/29/1999 | CA2649671A1 Progestin therapy for causing endometrial atrophy while maintaining amenorrhea |
| 04/29/1999 | CA2558783A1 Oral morphine multiparticulate formulation |
| 04/29/1999 | CA2308773A1 Estra-1,3,5(10)-triene-7alpha-thioethers |
| 04/29/1999 | CA2308769A1 Activating c1- secretion |
| 04/29/1999 | CA2308030A1 Delivery system for allergy medication via the nasal vestibules |
| 04/29/1999 | CA2307615A1 Progestin therapy with controlled bleeding |
| 04/29/1999 | CA2307613A1 Retinoic acid agonist as a prophylactic and therapeutic agent for nephritis |
| 04/29/1999 | CA2307597A1 Pharmaceutically active compounds and methods of use |
| 04/29/1999 | CA2307342A1 Method for suppressing multiple drug resistance in cancer cells |
| 04/29/1999 | CA2307322A1 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 04/29/1999 | CA2307308A1 Medicine for treatment of meniere's disease |
| 04/29/1999 | CA2307288A1 (3r,4r)-.delta.-tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents and analgesics |
| 04/29/1999 | CA2307199A1 2-substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-ht1a, 5-ht1b and 5-ht1d) |